Научно-практический журнал Медицинские технологии. Оценка и выбор
  • Русский
  • English

Health Technology Assessment in Scotland

Issue № 32 | 2018 (2)

DOI: https://doi.org/10.31556/2219-0678.2018.32.2.034-041 meta

Abstract

The article discusses the health technology assessment (HTA) in Scotland. The HTA is provided by the Scottish Medicines Consortium (SMC), that gives recommendations on the use of new registered drugs in the National Health Service of Scotland. New forms of release and new indications for the use of already existing drugs are assessed as well. The SMC assesses only new prescription drugs but not vaccines, generic drugs or blood products. The assessment procedures are strictly regulated. The experts use the specially designed checklists. The assessment is carried out on the basis of the data submitted by the applicant and filled in accordance with the established form (dossier). Clinical efficacy, safety, clinical and economic advantages of the drug in question are assessed. The file review takes about 18 weeks. Based on the assessment results, the SMC makes a conclusion on the possibility of financing the drug at the expense of the state budget. The SMC ‘s conclusions are recommendations only, the final decisions on the state financing of the drug are taken at the meetings of the country’s territorial health councils.

Keywords

health technology assessment, the Scottish Medicines Consortium, clinical checklist, economics checklist.

For citations

Teptsova N. S., Lemeshko V. A. Health Technology Assessment in Scotland. Medical Technologies. Assessment and Choice. 2018; 2(32): 34–41

mt_32_2018-2_34-41